000 01625 a2200433 4500
005 20250515002247.0
264 0 _c20060302
008 200603s 0 0 eng d
022 _a0091-3057
024 7 _a10.1016/j.pbb.2005.08.018
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSwerdlow, Neal R
245 0 0 _aReduced startle gating after D1 blockade: effects of concurrent D2 blockade.
_h[electronic resource]
260 _bPharmacology, biochemistry, and behavior
_cOct 2005
300 _a293-9 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, N.I.H., Extramural
650 0 4 _aAmphetamine
_xadministration & dosage
650 0 4 _aAnimals
650 0 4 _aBenzazepines
_xadministration & dosage
650 0 4 _aDepression, Chemical
650 0 4 _aDopamine Antagonists
_xadministration & dosage
650 0 4 _aDopamine D2 Receptor Antagonists
650 0 4 _aDopamine Uptake Inhibitors
_xadministration & dosage
650 0 4 _aHaloperidol
_xadministration & dosage
650 0 4 _aInjections
650 0 4 _aMale
650 0 4 _aPrefrontal Cortex
_xphysiology
650 0 4 _aRats
650 0 4 _aRats, Sprague-Dawley
650 0 4 _aReceptors, Dopamine D1
_xantagonists & inhibitors
650 0 4 _aReflex, Startle
_xdrug effects
700 1 _aShoemaker, Jody M
700 1 _aBongiovanni, Michele J
700 1 _aNeary, Alaina C
700 1 _aTochen, Laura S
700 1 _aSaint Marie, Richard L
773 0 _tPharmacology, biochemistry, and behavior
_gvol. 82
_gno. 2
_gp. 293-9
856 4 0 _uhttps://doi.org/10.1016/j.pbb.2005.08.018
_zAvailable from publisher's website
999 _c15819560
_d15819560